PortfoliosLab logoPortfoliosLab logo
GLP Weigh Loss
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Diversification

Asset Allocation


S&P 500 Index

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in GLP Weigh Loss , comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.


Loading graphics...

The earliest data available for this chart is Sep 13, 2019, corresponding to the inception date of HIMS

Returns By Period


1D1MYTD6M1Y3Y*5Y*10Y*
Benchmark
S&P 500 Index
0.11%-3.43%-3.84%-1.98%16.08%16.86%10.37%12.29%
Portfolio
GLP Weigh Loss
-0.21%-2.69%-5.46%8.30%20.99%25.85%29.22%
NVO
Novo Nordisk A/S
1.37%4.40%-24.78%-34.84%-43.28%-20.60%3.97%5.03%
MCK
McKesson Corporation
1.37%-11.19%7.89%16.76%28.01%35.09%36.27%19.69%
LLY
Eli Lilly and Company
-1.98%-7.16%-12.80%14.47%15.19%39.72%39.64%31.19%
AMGN
Amgen Inc.
-1.51%-7.71%7.04%18.64%17.39%16.07%10.31%11.72%
REGN
Regeneron Pharmaceuticals, Inc.
-1.98%-0.63%-1.18%27.29%22.44%-2.45%10.06%6.59%
AZN
AstraZeneca PLC
1.37%0.86%12.99%24.18%44.83%15.99%18.18%16.94%
ALNY
Alnylam Pharmaceuticals, Inc.
-3.01%0.06%-19.82%-30.83%19.50%16.68%17.59%16.79%
TEVA
Teva Pharmaceutical Industries Limited
-0.56%-6.82%-3.62%50.02%96.73%48.85%21.25%-5.34%
VKTX
Viking Therapeutics, Inc.
5.58%8.99%-1.08%24.82%35.51%25.58%40.84%37.04%
HIMS
Hims & Hers Health, Inc.
-3.53%20.99%-41.05%-66.93%-38.69%22.90%7.07%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Sep 16, 2019, GLP Weigh Loss 's average daily return is +0.11%, while the average monthly return is +2.27%. At this rate, your investment would double in approximately 2.6 years.

Historically, 63% of months were positive and 38% were negative. The best month was Feb 2024 with a return of +20.2%, while the worst month was Oct 2020 at -8.5%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 4 months.

On a daily basis, GLP Weigh Loss closed higher 53% of trading days. The best single day was Feb 27, 2024 with a return of +14.1%, while the worst single day was Mar 12, 2020 at -9.3%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20260.41%-0.24%-6.22%0.63%-5.46%
20251.19%4.57%-6.74%0.71%-0.64%0.58%-1.15%5.14%1.57%7.03%12.86%-0.71%25.76%
20248.35%20.24%4.85%-0.64%6.26%8.53%0.09%7.58%-6.87%-3.80%-4.93%-5.31%35.94%
20230.05%-2.43%9.45%5.34%-2.57%0.64%0.67%9.16%-1.39%-4.02%8.22%7.72%33.81%
2022-6.24%2.73%9.11%-4.44%2.33%-0.12%4.10%1.65%-3.40%13.39%5.48%11.91%40.43%
202110.80%-4.11%0.76%0.47%2.64%7.45%2.93%5.27%-4.79%1.61%-2.19%4.25%26.80%

Benchmark Metrics

GLP Weigh Loss has an annualized alpha of 20.30%, beta of 0.70, and R² of 0.38 versus S&P 500 Index. Calculated based on daily prices since September 16, 2019.

  • This portfolio captured 100.25% of S&P 500 Index gains but only 28.83% of its losses — a favorable profile for investors.
  • Beta of 0.70 may look defensive, but with R² of 0.38 this portfolio is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this portfolio's risk.
  • R² of 0.38 means the benchmark explains less than half of this portfolio's behavior — treat beta with caution or consider switching to a more representative benchmark.

Alpha
20.30%
Beta
0.70
0.38
Upside Capture
100.25%
Downside Capture
28.83%

Expense Ratio

GLP Weigh Loss has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.


The portfolio doesn't include any funds that charge management fees.

Return for Risk

Risk / Return Rank

GLP Weigh Loss ranks 25 for risk / return — below 25% of portfolios on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.


GLP Weigh Loss Risk / Return Rank: 2525
Overall Rank
GLP Weigh Loss Sharpe Ratio Rank: 2424
Sharpe Ratio Rank
GLP Weigh Loss Sortino Ratio Rank: 2323
Sortino Ratio Rank
GLP Weigh Loss Omega Ratio Rank: 1818
Omega Ratio Rank
GLP Weigh Loss Calmar Ratio Rank: 3636
Calmar Ratio Rank
GLP Weigh Loss Martin Ratio Rank: 2222
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics


PortfolioBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

0.86

0.88

-0.03

Sortino ratio

Return per unit of downside risk

1.31

1.37

-0.06

Omega ratio

Gain probability vs. loss probability

1.16

1.21

-0.04

Calmar ratio

Return relative to maximum drawdown

1.74

1.39

+0.35

Martin ratio

Return relative to average drawdown

5.21

6.43

-1.22


How much return does each position deliver for the risk it carries? Higher values mean better reward for the risk taken.

Risk / Return RankSharpe ratioSortino ratioOmega ratioCalmar ratioMartin ratio
NVO
Novo Nordisk A/S
11-0.80-0.970.87-0.78-1.35
MCK
McKesson Corporation
730.971.651.222.336.05
LLY
Eli Lilly and Company
510.360.781.110.561.37
AMGN
Amgen Inc.
590.601.071.131.102.65
REGN
Regeneron Pharmaceuticals, Inc.
590.560.971.141.072.72
AZN
AstraZeneca PLC
841.662.361.313.468.67
ALNY
Alnylam Pharmaceuticals, Inc.
540.480.971.120.661.45
TEVA
Teva Pharmaceutical Industries Limited
912.303.091.424.4412.79
VKTX
Viking Therapeutics, Inc.
590.461.111.171.012.23
HIMS
Hims & Hers Health, Inc.
25-0.380.031.00-0.49-0.96

Sharpe Ratio

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

GLP Weigh Loss Sharpe ratios as of Apr 2, 2026 (values are recalculated daily):

  • 1-Year: 0.86
  • 5-Year: 1.38
  • All Time: 1.28

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 1.01 to 1.70, this portfolio's current Sharpe ratio places it in the bottom 25%. This suggests weaker risk-adjusted returns than most portfolios, possibly due to lower returns, higher volatility, or both. It may be worth reviewing the allocation. You can use the Portfolio Optimization tool to explore options for improving the Sharpe ratio.

The chart below shows the rolling Sharpe ratio of GLP Weigh Loss compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.


Loading graphics...

Dividends

Dividend yield

GLP Weigh Loss provided a 1.56% dividend yield over the last twelve months.


TTM20252024202320222021202020192018201720162015
Portfolio1.56%1.22%1.09%0.93%1.00%1.11%1.29%1.33%1.37%1.83%2.14%1.41%
NVO
Novo Nordisk A/S
4.87%3.31%1.68%1.00%1.20%1.35%1.87%2.14%1.45%1.52%2.87%0.92%
MCK
McKesson Corporation
0.36%0.37%0.47%0.50%0.54%0.72%0.95%1.16%1.32%0.80%0.80%0.53%
LLY
Eli Lilly and Company
0.67%0.56%0.67%0.78%1.07%1.23%1.75%1.96%1.94%2.46%2.77%2.37%
AMGN
Amgen Inc.
2.78%2.91%3.45%2.96%2.95%3.13%2.78%2.41%2.71%2.65%2.74%1.95%
REGN
Regeneron Pharmaceuticals, Inc.
0.47%0.46%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
AZN
AstraZeneca PLC
2.62%1.70%2.27%2.15%2.12%2.35%2.80%2.81%3.69%3.95%5.01%4.06%
ALNY
Alnylam Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
TEVA
Teva Pharmaceutical Industries Limited
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%3.88%3.19%1.77%
VKTX
Viking Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
HIMS
Hims & Hers Health, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the GLP Weigh Loss . A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the GLP Weigh Loss was 29.72%, occurring on Apr 8, 2025. Recovery took 160 trading sessions.

The current GLP Weigh Loss drawdown is 9.07%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-29.72%Sep 3, 2024150Apr 8, 2025160Nov 25, 2025310
-21.83%Feb 13, 202027Mar 23, 202018Apr 17, 202045
-16.67%Jul 21, 202073Oct 30, 202052Jan 15, 2021125
-14.94%Apr 11, 202247Jun 16, 202233Aug 4, 202280
-13.76%Aug 16, 202229Sep 26, 202224Oct 28, 202253

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Diversification

Diversification Metrics


Number of Effective Assets

The portfolio contains 10 assets, with an effective number of assets of 8.67, reflecting the diversification based on asset allocation. This number of effective assets indicates a moderate level of diversification, where some assets may have a more significant influence on overall performance.

Asset Correlations Table

The table below displays the correlation coefficients between the individual components of the portfolio, the entire portfolio, and the chosen benchmark.

BenchmarkHIMSMCKTEVAALNYVKTXAZNNVOLLYREGNAMGNPortfolio
Benchmark1.000.370.320.410.340.360.290.360.350.360.400.54
HIMS0.371.000.070.210.240.270.100.170.130.120.130.30
MCK0.320.071.000.230.120.130.240.190.280.270.350.41
TEVA0.410.210.231.000.270.290.240.210.210.230.260.53
ALNY0.340.240.120.271.000.340.220.220.250.340.280.55
VKTX0.360.270.130.290.341.000.230.260.250.260.250.61
AZN0.290.100.240.240.220.231.000.430.380.340.390.55
NVO0.360.170.190.210.220.260.431.000.450.340.300.60
LLY0.350.130.280.210.250.250.380.451.000.370.400.64
REGN0.360.120.270.230.340.260.340.340.371.000.490.60
AMGN0.400.130.350.260.280.250.390.300.400.491.000.61
Portfolio0.540.300.410.530.550.610.550.600.640.600.611.00
The correlation results are calculated based on daily price changes starting from Sep 16, 2019